- Home
- NLSP vs LTRY Comparison
NLSP vs LTRY Comparison
Compare NLSP & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- LTRY
- Stock Information
- Founded
- NLSP 2015
- LTRY 2015
- Country
- NLSP Switzerland
- LTRY United States
- Employees
- NLSP N/A
- LTRY N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- LTRY Computer Software: Prepackaged Software
- Sector
- NLSP Health Care
- LTRY Technology
- Exchange
- NLSP Nasdaq
- LTRY Nasdaq
- Market Cap
- NLSP 243.8M
- LTRY N/A
- IPO Year
- NLSP 2021
- LTRY N/A
- Fundamental
- Price
- NLSP $4.96
- LTRY $0.49
- Analyst Decision
- NLSP
- LTRY
- Analyst Count
- NLSP 0
- LTRY 0
- Target Price
- NLSP N/A
- LTRY N/A
- AVG Volume (30 Days)
- NLSP 34.6K
- LTRY 52.0K
- Earning Date
- NLSP 11-01-2024
- LTRY 11-29-2024
- Dividend Yield
- NLSP N/A
- LTRY N/A
- EPS Growth
- NLSP N/A
- LTRY N/A
- EPS
- NLSP N/A
- LTRY N/A
- Revenue
- NLSP N/A
- LTRY $5,723,382.00
- Revenue This Year
- NLSP N/A
- LTRY N/A
- Revenue Next Year
- NLSP N/A
- LTRY N/A
- P/E Ratio
- NLSP N/A
- LTRY N/A
- Revenue Growth
- NLSP N/A
- LTRY 125.44
- 52 Week Low
- NLSP $4.08
- LTRY $0.50
- 52 Week High
- NLSP $29.68
- LTRY $7.01
- Technical
- Relative Strength Index (RSI)
- NLSP 46.37
- LTRY 34.24
- Support Level
- NLSP $4.52
- LTRY $0.51
- Resistance Level
- NLSP $5.64
- LTRY $0.57
- Average True Range (ATR)
- NLSP 0.48
- LTRY 0.03
- MACD
- NLSP 0.07
- LTRY 0.01
- Stochastic Oscillator
- NLSP 55.44
- LTRY 0.00
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.